Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study

Author： Wenying Yang   Benroubi Marian   Borzi Vito   Gumprecht Janusz   Kawamori Ryuzo   Shaban Joseph   Shah Siddharth   Shestakova Marina   Ligthelm Robert   Valensi Paul  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.11, 2009-11, pp. : 2643-2654

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study

By Meneghini L. F.   Dornhorst A.   Sreenan S.  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 1029-1035

Informa Healthcare

Access to resources Recommend Favorite

Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study

By Selam Jean-Louis   Koenen Christoph   Weng Wayne   Meneghini Luigi  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite

Assessment of quality of life in patients with type 2 diabetes mellitus before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy: IMPROVE study in Japan

By Ishii Hitoshi   Iwase Masanori   Seino Hiroaki   Shuto Yujin   Atsumi Yoshihito  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 643-650

Informa Healthcare

Access to resources Recommend Favorite

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

By Strojek Krzysztof   Bebakar Wan M.W.   Khutsoane Duma T.   Pesic Milica   Šmahelová Alena   Thomsen Henrik F.   Kalra Sanjay  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2887-2894

Informa Healthcare

Access to resources Recommend Favorite

Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin‐naïve or previously treated with insulin glargine: a randomized, double‐blind controlled trial (the ELEMENT 2 study)

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 8, 2015-08 ,pp. : 734-741

John Wiley & Sons Inc

Access to resources Recommend Favorite